Log in to search using one of your social media accounts:

 

Widely Used COPD Meds Tied to Increased Fracture Risk
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 13, 2018 Category: Respiratory Medicine Tags: Orthopedics, Pulmonology, Rheumatology, Geriatrics, News, Source Type: news

Nurses asked for views to help build respiratory health strategy
A new “taskforce for lung health”, comprising 25 representatives from the respiratory sector, is calling for evidence to identify what needs to change in the prevention and diagnosis of lung disease. (Source: Nursing Times)
Source: Nursing Times - February 13, 2018 Category: Nursing Source Type: news

Another Downside to Opioid Use: Pneumonia?
Title: Another Downside to Opioid Use: Pneumonia?Category: Health NewsCreated: 2/12/2018 12:00:00 AMLast Editorial Review: 2/13/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 13, 2018 Category: Respiratory Medicine Source Type: news

NIH study will assess biomarker as indicator of viral lower respiratory tract infection
(NIH/National Institute of Allergy and Infectious Diseases) A new clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, aims to determine whether low blood levels of the protein procalcitonin can reliably indicate whether a person's lower respiratory tract infection will improve with antibiotic treatment. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 13, 2018 Category: Infectious Diseases Source Type: news

EHRs Not Sufficient to Ensure Success in Value - Based Care
EHRs do not necessarily capture information needed; interoperability is poor, analytics are incomplete (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 13, 2018 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Another Downside to Opioid Use: Pneumonia?
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 12, 2018 Category: Respiratory Medicine Tags: Infections, Pharmacy, Pulmonology, News, Source Type: news

Think Extermination Ends Your Bedbug Woes? Think Again
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 12, 2018 Category: Respiratory Medicine Tags: Dermatology, Nursing, Pulmonology, News, Source Type: news

Inhaled Nitric Oxide Unhelpful for Very Premature Newborns in Respiratory Distress Inhaled Nitric Oxide Unhelpful for Very Premature Newborns in Respiratory Distress
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Pulmatrix doses first patient in Ph1 Pulmazole trial
Pulmatrix (NSDQ:PULM) said today that the first patient was treated in a first-in-human study of Pulmazole – an inhaled formulation of the anti-fungal drug, itraconazole. The Lexington, Mass.-based company is evaluating its iSperse formulation of the drug as a treatment for asthma patients who have developed allergic bronchopulmonary aspergillosis. Get the full story at our sister site, Drug Delivery Business News. The post Pulmatrix doses first patient in Ph1 Pulmazole trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Pulmatrix Inc. Source Type: news

Teva launches breath-activated asthma aerosol in U.S.
Teva Pharmaceuticals (NYSE:TEVA) has launched its Qvar RediHaler inhalation aerosol in the U.S., marking the first time a breath-actuated inhaled corticosteroid is available for asthma patients as a prophylactic therapy. In contrast to traditional metered-dose inhalers, Teva’s Qvar RediHaler sends medication into the user’s lungs as they inhale. This feature eliminates the need for hand-breath coordination, according to Teva. Get the full story at our sister site, Drug Delivery Business News. The post Teva launches breath-activated asthma aerosol in U.S. appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 12, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Teva Pharmaceuticals Source Type: news

Asbestos (Exposure Dangers, Testing, Symptoms)
Title: Asbestos (Exposure Dangers, Testing, Symptoms)Category: Diseases and ConditionsCreated: 2/21/2000 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 12, 2018 Category: Respiratory Medicine Source Type: news

East Africa:What's Likely to Kill You? Respiratory, Heart Diseases
[East African] Health experts are sounding the alarm over non-communicable diseases, which now top the list of the region's killers. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 12, 2018 Category: African Health Source Type: news

What Growth Charts Are Best?
Discussion “The value of growth assessment is thus its principal utility as a key screening tool in order to assess children’s general well-being, to identify faltering and excessive growth, to evaluate maternal lactation performance and infant feeding practices, and to manage her children with medical conditions known to adversely affect growth,….” Thus having assessment tools is important. Growth charts are assessment tools measuring height/length, weight, head circumference and body mass index. Some commonly used growth charts are: WHO child growth chart standards They were developed using lo...
Source: PediatricEducation.org - February 12, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medical News Today: Are there any home remedies for pneumonia?
A look a home remedies for pneumonia, a disorder with some symptoms you can manage at home. Included is detail on prevention and when to see a doctor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 11, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

2018 Annual Review of the Blueprint List of Priority Diseases
World Health Organization. 02/08/2018 This Web page provides the 2018 List of Priority Diseases, which include Ebola virus disease and Marburg virus disease, Lassa fever, Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS), and Zika virus. Experts consider that given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated research and development for these diseases. (Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - February 10, 2018 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Injury Scene Characteristics Linked to Injury Mortality
Increased odds of death for patients injured at locations farthest from level 1 or 2 trauma centers (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 10, 2018 Category: Respiratory Medicine Tags: Pulmonology, Surgery, Critical Care, Emergency Medicine, Journal, Source Type: news

Students with 9/11-related illnesses describe diagnoses
Former students of a high school that was engulfed in toxins after the Twin Towers exploded blocks away are being sickened by respiratory diseases and cancer more than 15 years after the attacks. (Source: the Mail online | Health)
Source: the Mail online | Health - February 9, 2018 Category: Consumer Health News Source Type: news

N8 Medical submits IDE app seeking 1st-in-human trial of CeraShield endotracheal tube
N8 Medical said today it submitted an investigational device exemption application to the FDA for a first-in-human study of its CeraShield endotracheal tube. The Dublin, Ohio-based company’s CeraShield ETT is a ceragenin-coated ETT designed to prevent the growth of biofilms and reduce potential for infection for intubated patients. “We are looking forward to bringing our breakthrough CeraShield endotracheal tube device to patients and hospitals that we believe will realize a substantial benefit,” prez & COO Ronald Bracken said in prepared remarks. N8 said it is hopeful it will be able to initiate huma...
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Respiratory n8medical Source Type: news

Innoviva posts Street-beating Q4, FY17 earnings
Shares in Innoviva (NSDQ:INVA) rose today after the company topped expectations on Wall Street with its fourth quarter and full-year financial results. The Brisbane, Calif.-based company posted profits of $58.4 million, or 55¢ per share, on sales of $69.5 million for the 3 months ended Dec. 31, for bottom-line growth of 129% on sales growth of 59% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Innoviva posts Street-beating Q4, FY17 earnings appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations MassDevice Earnings Roundup Pharmaceuticals Respiratory Wall Street Beat Innoviva Source Type: news

Respiratory Syncytial Virus Seasonality -- United States Respiratory Syncytial Virus Seasonality -- United States
A new statistical method is being used to more accurately determine respiratory syncytial virus seasonality nationally and by region.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 9, 2018 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

GlaxoSmithKline Sees Light at End of Advair Tunnel GlaxoSmithKline Sees Light at End of Advair Tunnel
GlaxoSmithKline sees growth strengthening over the next few years as the drugmaker weathers increased competition in its core respiratory and HIV businesses that could cause earnings to dip this year.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 8, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FDA rejects Novartis ’ Advair generic, leaving GSK without rival
GlaxoSmithKline (NYSE:GSK) was granted a temporary win today after Novartis‘ (NYSE:NVS) Sandoz unit reported that the FDA rejected its application for a generic version of the company’s blockbuster lung treatment, Advair. The regulatory agency reportedly told Novartis that it needs to submit additional clinical data before the FDA can make its final decision. Get the full story at our sister site, Drug Delivery Business News. The post FDA rejects Novartis’ Advair generic, leaving GSK without rival appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 8, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat GlaxoSmithKline plc Novartis sandoz Source Type: news

Preventing Vasospasm in Aneurysmal Subarachnoid Hemorrhage Preventing Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Which strategies may help prevent cerebral vasospasm among ICU patients with aneurysmal subarachnoid hemorrhage?Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

GlaxoSmithKline sees light at end of Advair tunnel
LONDON (Reuters) - GlaxoSmithKline sees growth strengthening over the next few years as the drugmaker weathers increased competition in its core respiratory and HIV businesses that could cause earnings to dip this year. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

GSK cautious on 2018, as drug competition looms, after fourth-quarter beats
LONDON (Reuters) - GlaxoSmithKline said on Wednesday its earnings could slip this year, after a better-than-expected performance in the fourth quarter, as the drugmaker faces increased competition in its core respiratory and HIV businesses. (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Bronchitis (Acute) Symptoms, Causes, Treatment Remedies, and Cures
Title: Bronchitis (Acute) Symptoms, Causes, Treatment Remedies, and CuresCategory: Diseases and ConditionsCreated: 9/2/2005 12:00:00 AMLast Editorial Review: 2/7/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 7, 2018 Category: Respiratory Medicine Source Type: news

Asthma Attacks on the Decline Among U.S. Kids
Title: Asthma Attacks on the Decline Among U.S. KidsCategory: Health NewsCreated: 2/6/2018 12:00:00 AMLast Editorial Review: 2/7/2018 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - February 7, 2018 Category: Respiratory Medicine Source Type: news

Research suggests vapers are vulnerable to pneumonia
(European Lung Foundation) The vapor from e-cigarettes seems to help pneumonia-causing bacteria stick to the cells that line the airways, according to research published in the European Respiratory Journal. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 7, 2018 Category: Infectious Diseases Source Type: news

Time of Death: New AI Technology Tries To Predict and Prevent Death
If you could know the exact day you die, would you want to? The question may not be as far-fetched as you might think, thanks to a new algorithm designed to analyze digital medical records and compare them to real-time health data to calculate the risk of impending health events. The FDA cleared technology from Excel Medical, known as the WAVE Clinical Platform, is being billed as the world’s first patient surveillance and predictive algorithm platform. The device was designed as an always-on remote monitoring platform that can track real-time data, such as vital signs, and use that information in conj...
Source: MDDI - February 7, 2018 Category: Medical Devices Authors: Kristopher Sturgis Tags: Digital Health Source Type: news

Study: Early Identification Needed for Mesothelioma Advances
Professor John Cherrie at Heriot-Watt University in the United Kingdom believes future treatment advances and improved patient outcomes for mesothelioma rests with a formula to better identify and screen high-risk patients. It could make an early diagnosis of the asbestos-related cancer much more common. Cherrie said the current standard — which typically results in a late-stage diagnosis and a poor prognosis — prevents novel treatment studies and the development of any pre-emergent strategy to combat the aggressive cancer. “We don’t pretend to have a medical cure that will help immediately, but un...
Source: Asbestos and Mesothelioma News - February 6, 2018 Category: Environmental Health Authors: Matt Mauney Tags: Activity emission potential biomarkers for mesothelioma chemoprophylaxis strategies early diagnosis mesothelioma Early identification of mesothelioma early screening asbestos Heriot-Watt University high-risk mesothelioma indwelling pleural Source Type: news

Study: Long-term use of inhaled corticosteroids may heighten risk of bone fractures in COPD patients
Researchers reported this month that in men and women with chronic obstructive pulmonary disease, long-term use of inhaled corticosteroids may be linked to an increased risk of bone fractures. Previous research has shown that the inhaled drugs, used to treat COPD, impact bone mineral density based on the dose of the corticosteroid, especially in post-menopausal women. Get the full story at our sister site, Drug Delivery Business News. The post Study: Long-term use of inhaled corticosteroids may heighten risk of bone fractures in COPD patients appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 6, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Research & Development Respiratory Novartis Source Type: news

What to Eat (and Drink) When You Have the Flu
This article originally appeared on Health.com (Source: TIME: Health)
Source: TIME: Health - February 6, 2018 Category: Consumer Health News Authors: Amanda MacMillan / Health.com Tags: Uncategorized flu healthytime onetime Source Type: news

Harmless strains of Aspergillus prevent maize crop loss, by competing out toxic strains
Tue, 02/06/2018 - 11:53News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 6, 2018 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

The 2nd Manchester Cystic Fibrosis Conference: Facing the Challenges of Today
Date: Tuesday, February 6, 2018Year: 2018Location: Stoller Hall - Chetham's School of Music, Hunts Bank, Manchester, M31DAContent-type: current_conferences (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 6, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life Expectancy
Title: COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life ExpectancyCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/6/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 6, 2018 Category: Respiratory Medicine Source Type: news

COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life Extpectancy
Title: COPD (Chronic Obstructive Pulmonary Disease) Symptoms, Causes, Stages, Life ExtpectancyCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/6/2018 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 6, 2018 Category: Respiratory Medicine Source Type: news

Easing Your Child's Asthma
Title: Easing Your Child's AsthmaCategory: Health NewsCreated: 2/6/2018 12:00:00 AMLast Editorial Review: 2/6/2018 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - February 6, 2018 Category: Respiratory Medicine Source Type: news

Teleflex wins FDA nod for next-gen peripheral snares, launches in US
Teleflex (NYSE:TFX) said today it won FDA 510(k) clearance for its Expro Elite and Sympro Elite peripheral interventional snares and that it launched the devices in the US. Both newly cleared snares are next-generation versions of 0.035″ interventional snares launched in the US in 2008 by Vascular Solutions, which is now a wholly-owned subsidiary of Teleflex. The Expro Elite snare is designed to use a helical loop for all-direction capturing, and the Sympro Elite snare is designed to use a 90-degree loop which remains coaxial to the vessel, the Wayne, Penn.-based company said. Both devices are designed for ...
Source: Mass Device - February 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Vascular Teleflex Source Type: news

Amiko wins CE Mark to integrate drug sensor tech into inhalers
Amiko Digital Health said today that it received CE Mark clearance to integrate its Respiro medication sensor tech with Teva Pharmaceuticals‘ (NYSE:TEVA) Spiromax inhaler, Chiesi‘s Nexthaler device and GlaxoSmithKline‘s (NYSE:GSK) Ellipta inhaler. The company’s Respiro platform is designed to help doctors monitor, in real-time, when and how well patients are using their medications. Get the full story at our sister site, Drug Delivery Business News. The post Amiko wins CE Mark to integrate drug sensor tech into inhalers appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat amiko chiesigroup GlaxoSmithKline plc Teva Pharmaceuticals Source Type: news

8th Advances Against Aspergillosis Conference Round-Up
Mon, 02/05/2018 - 14:02News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - February 5, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Regular physical activity is associated with better lung function among smokers
(Barcelona Institute for Global Health (ISGlobal)) The results of this ISGlobal study strengthen the epidemiological evidence supporting a link between physical activity and respiratory health (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 5, 2018 Category: International Medicine & Public Health Source Type: news

What is the Difference Between an Association and a Syndrome?
Discussion VATER association was first described in the 1970s with additional congenital malformations being added to the association so it is most often called VACTERL association. It is a highly heterogeneous, overlapping condition estimated to occur in ~1/10,000-40,000 births. The cause is unknown. In animal models, some signaling pathway gene mutations have phenotypes of VACTERL association. Experts suggest that patients having at least 2 components should be further evaluated (at least 3 for diagnosis) for VACTERL and other diseases in its differential diagnosis. There are more than 30 syndromes, mutations and diseas...
Source: PediatricEducation.org - February 5, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Respicardia launches Remed ē system, taps Sommerness as CEO
Respicardia said today it launched its Remedē transvenous implantable neurostimulation system designed to treat patients with central sleep apnea, and that it named Peter Sommerness as CEO. The Remedē system consists of a surgically placed battery pack and thin wires inserted into the blood vessels in the chest near the phrenic nerve, which it stimulates to engage the diaphragm to restore natural breathing during sleep and improve patient quality of life and satisfaction. “Central sleep apnea is very common in cardiac patients, especially patients with heart failure, and is associated with a significantly grea...
Source: Mass Device - February 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Respiratory Respicardia Source Type: news

Persistent Respiratory Issues in Youth May Decline Lung Function
Respiratory symptoms also associated with increased odds of incident and restrictive physiology (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - February 2, 2018 Category: Respiratory Medicine Tags: Pediatrics, Pulmonology, Journal, Source Type: news

Weekend Recipe: A Hearty Chicken Soup That ’s Good for Your Soul and Immune System
When I feel a little run down, I make my restorative Polish-style chicken soup called Rosół, which was taught to me by my great-grandmother to help fight colds. When I ate her soup, I could instantly feel its healing effects and it just made me feel good all over. Chicken soup is simply a protein-rich meat stock, infused with a mirepoix of vegetables such as carrots, onion and leek. After simmering for 1 ½ to 2 hours, you end up with a golden elixir that’s filled with nutrients from the organic chicken meat and vegetables that you’ve used. It can be sipped all day, or made into a more substantial...
Source: TIME: Health - February 1, 2018 Category: Consumer Health News Authors: Teresa Cutter — The Healthy Chef Tags: Uncategorized Food healthytime Recipes Teresa Cutter The Healthy Chef Source Type: news

FDA recall of Vyaire AirLife humidification chambers is Class I
The FDA today released a Class I recall notice for select Vyaire Medical AirLife humidification chambers and heated breathing circuit kits over a manufacturing error that could cause the chamber to split and allow water into the patient’s breathing circuit. Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The AirLife humidification chamber and heated breathing circuit kits are designed for use with invasive and non-invasive ventilation systems to provide humidif...
Source: Mass Device - February 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Recalls Respiratory Vyaire Medical Source Type: news

Blind Insertion or Blindly Inserted: Advanced Airways Revisited
Blind insertion or blindly inserted? One thing we do in EMS that many of us most pride ourselves on is advanced airway management—though gaining that pride may have required a few moments of pants-wetting terror along the way. For patients in respiratory failure rapidly progressing to respiratory or cardiac arrest, there are few scenarios that run us right up against the front lines of life and death, and with so much potential to affect the outcome. These cases bring into focus the cognitive (knowledge), psychomotor (manual), and affective (emotional/psychological) elements of our job like nothing else we do. Yet ev...
Source: JEMS Patient Care - February 1, 2018 Category: Emergency Medicine Authors: Neal Richmond, MD Tags: Patient Care Columns Source Type: news

Zurich ’s Air Medical Program Flies Seven ECMO Missions in Ten Days
In a ten day period in January, Rega aircraft in Zurich, Switzerland transported and cared for a total of seven patients, including a two-year-old child, with the most severe cardiovascular and pulmonary disease. This was made possible by a small, portable heart-lung extracorporeal membrane oxygenation (ECMO) machine, which is compatible with both the ambulance jets, and the two types of helicopters used by Rega. Since 2009, Rega has been the only air rescue organization in Switzerland to have its own ECMO equipment. The devices have been instrumental in the care and transport of 25 intensive care patients annually. That&r...
Source: JEMS Patient Care - February 1, 2018 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Cardiac & Resuscitation Patient Care Operations Source Type: news

Zurich ’s Air Medical Program Flies Seven ECMO Missions in Ten Days
In a ten day period in January, Rega aircraft in Zurich, Switzerland transported and cared for a total of seven patients, including a two-year-old child, with the most severe cardiovascular and pulmonary disease. This was made possible by a small, portable heart-lung extracorporeal membrane oxygenation (ECMO) machine, which is compatible with both the ambulance jets, and the two types of helicopters used by Rega. Since 2009, Rega has been the only air rescue organization in Switzerland to have its own ECMO equipment. The devices have been instrumental in the care and transport of 25 intensive care patients annually. That&r...
Source: JEMS Operations - February 1, 2018 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Cardiac & Resuscitation Patient Care Operations Source Type: news

Induced labor after 39 weeks in healthy women may reduce need for C section
NIH-funded study suggests this approach may also reduce risk of preeclampsia, need for newborn respiratory support. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 1, 2018 Category: American Health Source Type: news